forgemax.FORGED. TESTED. PROVEN.
Nolvaxyl 20mg/tab 30 Tabletten by Kalpa Pharmaceuticals
GMP Standard

Nolvaxyl 20mg/tab 30 Tabletten by Kalpa Pharmaceuticals

5 (2 reviews)

Nolvaxyl by Kalpa Pharmaceuticals is a pharmaceutical-grade selective estrogen receptor modulator supplying Tamoxifen Citrate at 20 mg per tablet across a 30-tablet blister pack, engineered around the structural difference between oral-only and injectable anabolic cycle recovery windows. Oral androgens vacate the bloodstream within 24–72 hours of the final dose, whereas long-ester injectable compounds sustain an androgenic depot for up to three weeks post-injection — a pharmacokinetic gap that makes a fixed 20 mg denomination the most practical tool for aligning PCT initiation with actual compound clearance. Kalpa Pharmaceuticals verifies each production lot through incoming API quantification by HPLC and finished-tablet content-uniformity testing before any batch enters the distribution chain.

€32.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Precise 20 mg fixed dose eliminates unit-stacking for both oral-cycle and injectable-cycle PCT induction.
  • Rapid initiation flexibility — suitable for same-day start after oral compound clearance.
  • Consistent receptor occupancy maintained by Tamoxifen's active metabolite half-life of 5–7 days.
  • GMP Standard manufacturing with dual-checkpoint analytical release: HPLC potency and tablet content uniformity.
  • 30-tablet count covers a complete oral-cycle PCT or the induction phase of an injectable-cycle protocol.
  • Single-ingredient formulation eliminates variable absorption from excipient-heavy blended preparations.
  • Blister-sealed individual tablets preserve active ingredient stability across multi-week outdoor or travel use.

Key takeaways

  • Begin Nolvaxyl within 24 hours of your last oral androgenic compound.
  • Delay PCT start 10–21 days after the final long-ester injectable dose.
  • Match cycle type to timing — oral and injectable protocols differ structurally.
  • Choose 20 mg/tab for single-tablet induction without extra unit stacking.
  • Verify batch quality through GMP Standard HPLC and content-uniformity records.

Oral vs. Injectable Cycles: Why PCT Start Timing Is Not Uniform

Nolvaxyl defines itself as the dose-fixed SERM tool for athletes whose PCT start date is governed by cycle type — specifically whether the androgens used were orally bioavailable, short-acting compounds or long-ester injectables with multi-week tissue residency. The timing gap between the last anabolic dose and the first Tamoxifen tablet is not arbitrary; it is dictated by compound pharmacokinetics. An oral-only cycle built around compounds such as Methandrostenolone or Oxandrolone produces peak blood-level clearance within 24–72 hours of cessation, meaning Tamoxifen Citrate can be initiated almost immediately — typically the day after the final oral dose — without risking SERM-androgen antagonism. Injectable cycles using long esters (Testosterone Enanthate, Testosterone Cypionate, Nandrolone Decanoate) require a washout window of 10–21 days before SERM therapy begins, because residual esterified androgen still clearing from depot sites would blunt the hypothalamic feedback signal Tamoxifen is intended to restore.

Pharmacokinetic Foundations of the Oral-vs-Injectable Distinction

Tamoxifen Citrate binds selectively to estrogen receptors in the hypothalamic-pituitary region, removing the negative feedback signal that suppressed gonadotropin output during the anabolic cycle. The active moiety, 4-hydroxytamoxifen, carries a plasma half-life of approximately 5–7 days, which allows once-daily dosing to maintain consistent receptor occupancy throughout the recovery window. Compared to short-ester or oral androgen cycles — where hormonal suppression is present but depot-free — long-ester injectable cycles impose a sustained androgenic environment for weeks post-injection; initiating Nolvaxyl before ester clearance is complete produces a less effective pituitary signal and may extend the total recovery timeline unnecessarily. The 20 mg per tablet denomination accommodates the full induction dose in a single daily tablet for oral-cycle PCT, while the same unit supports the graduated dose reduction typical of longer injectable-cycle protocols simply by maintaining the standard schedule across additional weeks.

GMP Standard Manufacturing and Analytical Release

Kalpa Pharmaceuticals subjects each Nolvaxyl batch to two mandatory analytical checkpoints before distribution: incoming Tamoxifen Citrate API is quantified by HPLC against a certified reference standard at acceptance, and finished tablets undergo content-uniformity assessment to confirm the declared 20 mg survives the compression and tableting process intact. Both tests must yield compliant results before any batch is released to the distribution network. The 30-tablet pack size maps onto a three-to-four-week oral-cycle PCT or the induction-plus-tapering phase of a longer injectable-cycle recovery, providing a logical supply unit without necessitating mid-protocol reorder for the majority of cycle types.

Usage

  1. Identify cycle type (oral-only vs. injectable) and determine the correct PCT start date: day after last oral dose, or 14–21 days after the final injectable, depending on ester length.
  2. Set a calendar reminder for the PCT start date before the cycle ends — supply logistics differ, and Nolvaxyl should be on hand before the cycle concludes, not ordered reactively.
  3. Take one 20 mg Nolvaxyl tablet once daily with a small meal to minimise the incidence of gastric discomfort, which is the most commonly reported dose-related complaint.
  4. For injectable-cycle PCT: confirm the washout period is genuinely complete by tracking injection date and the known half-life of the longest-acting compound used; do not estimate.
  5. Run bloodwork (LH, FSH, Total Testosterone) at baseline (PCT day 1), mid-protocol (week 3), and at protocol conclusion to objectively determine whether recovery targets have been reached.
  6. Do not extend the Nolvaxyl protocol indefinitely without bloodwork confirmation; discontinue when hormone markers return to pre-cycle reference range to avoid unnecessary prolonged SERM exposure.

Warnings

Contraindications: Nolvaxyl is contraindicated in individuals with a personal or family history of thromboembolic events, established hypersensitivity to Tamoxifen Citrate, or concurrent use of combined hormonal contraceptives. It is not indicated for females within this context and should not be used alongside potent CYP2D6 inhibitors (certain antidepressants, antifungals) that reduce conversion to the active 4-hydroxytamoxifen metabolite.

Side_Effects: Reported side effects include hot flushes, transient visual disturbances, mood variability, and altered lipid profiles (potential reduction in HDL cholesterol). Ocular effects — including rare cases of visual field changes — warrant immediate medical review if they arise during a PCT course. Nausea and headache are dose-related and typically resolve within the first week.

Monitoring: Conduct liver enzyme assessment (ALT, AST) if Nolvaxyl follows a hepatotoxic oral AAS cycle, as the liver may still be under stress at PCT initiation. Lipid panels and complete testosterone/gonadotropin panels are the minimum monitoring framework for all PCT protocols regardless of cycle type.

PCT: The timing difference between oral and injectable PCT protocols is clinically significant: initiating Tamoxifen while residual long-ester androgen remains biologically active delays productive hormonal recovery. Confirm ester clearance before starting; premature initiation is the most avoidable error in injectable-cycle PCT planning.

Frequently asked questions

When should you start Tamoxifen after an oral-only steroid cycle?
You can begin Tamoxifen Citrate the day after your final oral androgenic dose in most oral-only cycles, because compounds like Methandrostenolone and Oxandrolone clear plasma within 24–72 hours. There is no long ester creating a washout delay, so initiating Nolvaxyl at 20 mg/day within 24 hours of the last tablet is both safe and mechanistically appropriate for restoring pituitary output promptly.
How long do you wait before starting PCT after a long-ester injectable cycle?
A washout period of 10–21 days is standard after the last injection of long-ester androgens such as Testosterone Enanthate or Testosterone Cypionate. Residual esterified hormone continues releasing from the depot during this window; starting Nolvaxyl too early, while significant androgen is still present, reduces the effectiveness of the pituitary SERM signal and does not meaningfully accelerate recovery.
What role does the half-life of the last injectable compound play in PCT timing?
Half-life directly determines when esterified androgen drops to a level low enough that hypothalamic receptors will respond to Tamoxifen's estrogen-blocking action. As a guideline, practitioners wait approximately five half-lives of the last injectable before initiating SERM therapy — roughly 14 days for Testosterone Enanthate — ensuring the androgenic signal has diminished sufficiently that the pituitary can resume LH and FSH production in response to the receptor blockade.
Why does Nolvaxyl's 20 mg tablet strength matter for both oral and injectable PCT protocols?
At 20 mg per tablet, Nolvaxyl delivers the full standard induction dose in one tablet daily — eliminating the need to combine multiple lower-strength units. For oral-cycle PCT, that single-tablet induction dose is typically maintained for 2–3 weeks. For injectable-cycle PCT, the same 20 mg unit covers the induction phase and can be halved only if the practitioner chooses a tapering phase, making it the most dosing-versatile denomination in the Tamoxifen Citrate product group.
How does the 30-tablet pack fit a standard PCT after an oral vs. an injectable cycle?
For an oral-only cycle, 30 tablets at 20 mg/day covers a complete three-to-four-week recovery protocol without requiring a second order. For injectable cycle PCT — which begins later and may extend to six weeks — the 30-tablet pack covers the front-loaded induction phase, after which a second smaller pack handles the taper; knowing this in advance allows athletes to plan supply before the cycle ends. (2) angle_used

Manufacturer

Kalpa Pharmaceuticals reaches international bodybuilding markets through a structured authorised distributor network rather than direct-to-consumer fulfilment — a distribution architecture that keeps product handling under defined chain-of-custody conditions from post-production warehouse to final delivery. For Nolvaxyl specifically, this matters because Tamoxifen Citrate tablets are moisture-sensitive: individual blister sealing at the production stage is the first protective layer, but maintaining that integrity across logistics requires temperature-controlled storage and transit standards that authorised distributors within Kalpa's network are contractually required to meet. Regional distribution hubs in key markets reduce transit time, which is a secondary but genuine quality-preservation factor for a SERM product whose potency depends on API stability remaining uncompromised at point of use. Customers ordering Nolvaxyl through authorised channels receive product accompanied by batch documentation that traces the unit back through the two analytical release checkpoints — HPLC API quantification and finished-tablet content uniformity — enabling independent verification of the declared 20 mg specification without reliance on manufacturer self-reporting alone.

Product details

BrandKalpa Pharmaceuticals
Active ingredienttamoxifene citrate
Also known asTamoxifen, Nolvadex, Tamoxifen Citrate, Nolvaxyl, Kalpa Pharmaceuticals Tamoxifen
Strength20 mg
FormTabletten
Pack size30 pieces
Item numberPCT-TAMO-KAL-006

Reviews

5/5

2 reviews

  • Rating: 5 out of 5 starsapollo_15Verified purchase

    Kept gyno at bay

    noticed some sensitivity behind my left nipple around week 6 of a deca and test cycle. started nolva at 20mg ED and it was gone within 10 days. also used it for PCT at 40/40/20/20 and my LH and FSH both came back in range on bloods. cholesterol moved slightly but nothing alarming. reliable tabs, consistent dosing

  • Rating: 5 out of 5 starsproVerified purchase

    Standard nolva, works great

    been using nolvadex for PCT for years and this batch is spot on. 40mg for 2 weeks then 20mg for 2 weeks post 12 week cycle. felt back to normal energy and mood by week 3. no complaints, arrived well packaged

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Nolvadex 10mg/tab 50 Tablets by Beligas PharmaceuticalsLab Tested

Nolvadex 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

€40.00
TamoTrex 20mg/tab 50 Tablets by Concentrex LabsHPLC Verified

TamoTrex 20mg/tab 50 Tabletten by Concentrex Labs

€45.00
Zymoplex 20mg/tab 30 Tablets by GenepharmPharma Grade

Zymoplex 20mg/tab 30 Tabletten by Genepharm

€16.00
Tamoxifen Tablets 10mg/tab 100 Tablets by GenesisPurity Tested

Tamoxifen Tablets 10mg/tab 100 Tabletten by Genesis

€26.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00